Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Nanomedicine"
DOI: 10.2147/ijn.s153795
Abstract: Introduction Nanoparticles (NPs) modified with bio-ligands represent a promising strategy for active targeted drug delivery to tumour. However, many targeted ligands, such as trastuzumab (TMAB), have high molecular weight, limiting their application for targeting. In…
read more here.
Keywords:
fab cur;
cur nps;
cur;
tmab cur ... See more keywords